These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27399265)

  • 1. Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma.
    Steineck A; MacKenzie JD; Twist CJ
    Pediatr Blood Cancer; 2016 Nov; 63(11):2050-3. PubMed ID: 27399265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
    Reynolds CP
    Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
    Maurer BJ; Kang MH; Villablanca JG; Janeba J; Groshen S; Matthay KK; Sondel PM; Maris JM; Jackson HA; Goodarzian F; Shimada H; Czarnecki S; Hasenauer B; Reynolds CP; Marachelian A
    Pediatr Blood Cancer; 2013 Nov; 60(11):1801-8. PubMed ID: 23813912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
    Villablanca JG; London WB; Naranjo A; McGrady P; Ames MM; Reid JM; McGovern RM; Buhrow SA; Jackson H; Stranzinger E; Kitchen BJ; Sondel PM; Parisi MT; Shulkin B; Yanik GA; Cohn SL; Reynolds CP
    Clin Cancer Res; 2011 Nov; 17(21):6858-66. PubMed ID: 21908574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
    ; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP
    J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature.
    Duvalyan A; Cha A; Goodarzian F; Arkader A; Villablanca JG; Marachelian A
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28236. PubMed ID: 32386124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid therapy of childhood cancer.
    Reynolds CP; Lemons RS
    Hematol Oncol Clin North Am; 2001 Oct; 15(5):867-910. PubMed ID: 11765378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.
    Garaventa A; Luksch R; Lo Piccolo MS; Cavadini E; Montaldo PG; Pizzitola MR; Boni L; Ponzoni M; Decensi A; De Bernardi B; Bellani FF; Formelli F
    Clin Cancer Res; 2003 Jun; 9(6):2032-9. PubMed ID: 12796365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs.
    Lovat PE; Ranalli M; Bernassola F; Tilby M; Malcolm AJ; Pearson AD; Piacentini M; Melino G; Redfern CP
    Int J Cancer; 2000 Dec; 88(6):977-85. PubMed ID: 11093824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth Failure Caused by Premature Epiphyseal Closure in a Child Treated with Isotretinoin for Neuroblastoma.
    Hoemberg S; Reinhard H
    Klin Padiatr; 2017 May; 229(3):175-176. PubMed ID: 28561229
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
    Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
    Oncol Rep; 2003; 10(5):1587-92. PubMed ID: 12883745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review.
    Alazawi S; Hendriksz T
    J Osteopath Med; 2021 Oct; 122(1):45-53. PubMed ID: 34626532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
    Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
    Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.
    Villablanca JG; Khan AA; Avramis VI; Reynolds CP
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):410-5. PubMed ID: 8214363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physeal Abnormalities in Children With High-risk Neuroblastoma Intensively Treated With/Without 13-Cis-Retinoic Acid.
    Koh KN; Jeon JY; Park SS; Im HJ; Kim H; Kang MS
    J Pediatr Orthop; 2021 Oct; 41(9):e841-e848. PubMed ID: 34387230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genu varum deformity due to premature epiphyseal closure after treatment with isotretinoin for neuroblastoma: A case report.
    Park WK; Choi HS; Chung CY; Park MS; Sung KH
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020924483. PubMed ID: 32425129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.
    Masetti R; Biagi C; Zama D; Vendemini F; Martoni A; Morello W; Gasperini P; Pession A
    Adv Ther; 2012 Sep; 29(9):747-62. PubMed ID: 22941525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives.
    Cooper JP; Reynolds CP; Cho H; Kang MH
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1178-1184. PubMed ID: 28429653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized metaphyseal modification with cone-shaped epiphyses following long-term administration of 13-cis-retinoic acid.
    Nishimura G; Mugishima H; Hirao J; Yamato M
    Eur J Pediatr; 1997 Jun; 156(6):432-5. PubMed ID: 9208235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenretinide and its relation to cancer.
    Ulukaya E; Wood EJ
    Cancer Treat Rev; 1999 Aug; 25(4):229-35. PubMed ID: 10448131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.